Loading...

APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 33 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 116 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  3. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  4. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  5. Huis In 't Veld LGM, et al. 2022. Cell Mol Life Sci. 79:231. PubMed
  6. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  7. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  8. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  9. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  10. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  11. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  12. Guasconi L, et al. 2022. J Fungi (Basel). 8: . PubMed
  13. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  14. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  15. Klaus T, et al. 2022. JCI Insight. 7: . PubMed
  16. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  17. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  18. Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed
  19. Taniguchi S, et al. 2023. Nat Commun. 14:143. PubMed
  20. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  21. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  22. Duan H, et al. 2022. Adv Sci (Weinh). 9:e2103719. PubMed
  23. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  24. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  25. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  26. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  27. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  28. Shi X, et al. 2023. iScience. 26:106143. PubMed
  29. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  30. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  31. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  32. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  33. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  34. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  35. Song J, et al. 2023. iScience. 26:106753. PubMed
  36. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  37. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  38. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  39. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  40. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  41. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  42. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  43. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  44. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  45. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  46. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  47. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  48. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  49. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  50. Page N, et al. 2018. Immunity. 48:937. PubMed
  51. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  52. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  53. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  54. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  55. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  56. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  57. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  58. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  59. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  60. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  61. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  62. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  63. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  64. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  65. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  66. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  67. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  68. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  69. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  70. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  71. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  72. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  73. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  74. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  75. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  76. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  77. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  78. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  79. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  80. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  81. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  82. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  83. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  84. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  85. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  86. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  87. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  88. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  89. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  90. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  91. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  92. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  93. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  94. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  95. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  96. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  97. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  98. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  99. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  100. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  101. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  102. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  103. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  104. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  105. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  106. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  107. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  108. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  109. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  110. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  111. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  112. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  113. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  114. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  115. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  116. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  117. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  118. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  119. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  120. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  121. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  122. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  123. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  124. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  125. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  126. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  127. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  128. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  129. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  130. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  131. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  132. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  133. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  134. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  135. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  136. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  137. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  138. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  139. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  140. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  141. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  142. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  143. Li N, et al. 2021. eLife. 10:00. PubMed
  144. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  145. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  146. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  147. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  148. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  149. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  150. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  151. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  152. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  153. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  154. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  155. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  156. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  157. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  158. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  159. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  160. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  161. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  162. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  163. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  164. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  165. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  166. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  167. He J, et al. 2019. J Clin Invest. 130. PubMed
  168. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  169. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  170. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  171. Kim S, et al. 2021. Elife. 10:. PubMed
  172. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  173. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  174. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  175. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  176. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  177. White C, et al. 2015. J Immunol. 194:697. PubMed
  178. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  179. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  180. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  181. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  182. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  183. Lang V, et al. 2021. Elife. 10:. PubMed
  184. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  185. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  186. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  187. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  188. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  189. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  190. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  191. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  192. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  193. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  194. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  195. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  196. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  197. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  198. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  199. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  200. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  201. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  202. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  203. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  204. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  205. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  206. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  207. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  208. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  209. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  210. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  211. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  212. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  213. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  214. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  215. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  216. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  217. Li C, et al. 2018. Cell. 174:285. PubMed
  218. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  219. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  220. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  221. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  222. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  223. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  224. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  225. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  226. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  227. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  228. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  229. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  230. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  231. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  232. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  233. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  234. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  235. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  236. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  237. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  238. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  239. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  240. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  241. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  242. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  243. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  244. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  245. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  246. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  247. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  248. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  249. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  250. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  251. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  252. Smith LK, et al. 2021. Elife. 10:. PubMed
  253. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  254. Li H, et al. 2022. iScience. 25:104481. PubMed
  255. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  256. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  257. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  258. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  259. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  260. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  261. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  262. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  263. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  264. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  265. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  266. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  267. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  268. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  269. Zhang B, et al. 2021. Nature. 599:471. PubMed
  270. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  271. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  272. Gawish R, et al. 2022. Elife. 11:. PubMed
  273. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  274. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  275. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  276. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  277. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  278. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  279. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  280. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  281. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  282. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  283. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  284. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  285. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  286. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  287. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account